Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Nov-Dec;25(6):477-80.
doi: 10.5144/0256-4947.2005.477.

Insulinoma in Iran: a 20-year review

Bagher Larijani  1 , Shahriar Aghakhani, Shams Sadat Moosavi Lor, Zahedi Farzaneh, Mohammad Pajouhi, Mohammad Hasan Bastanhagh
Affiliations

Insulinoma in Iran: a 20-year review

Bagher Larijani et al. Ann Saudi Med. 2005 Nov-Dec.

Abstract

Background: The time between onset of symptoms of insulinoma to diagnosis ranges from 10 days to more than 20 years. To help physicians make an earlier diagnosis, we defined the clinical, imaging and paraclinical characteristics of insulinoma in cases from seven referral hospitals in Iran over two decades.

Methods: The medical records of 68 cases with biochemical or histological evidences of insulinoma were reviewed.

Results: More males were affected (53%). The mean age at diagnosis was 39 +/- 15.3 years. The mean duration of symptoms was 39.9 +/- 59.3 months. Eighty-four percent of patients had been initially misdiagnosed as cereberovascular accident (CVA), epilepsy, conversion disorder, and others). Neuroadrenergic symptoms were observed in 89.6% and and neuroglycopenic symptoms in 97% of patients. Mean diameter of tumours was 2.9 cm (range, 1 cm to 8.5 cm). Of 52 pathologically confirmed cases of insulinoma, 43 tumours (87.8%) were single and 49 (94.2%) were benign. Fifty-five patients had undergone surgery, with a successful outcome in 44 (80%).

Conclusion: The high incidence of neuroglycopenic symptoms suggest the clinical impression of insulinoma when patients present with a suggestive clinical syndrome. The clinical impression is essential to decrease the frequent delay in the diagnosis of insulinoma.

PubMed Disclaimer

References

    1. Service FJ, McMahon MM, O’Brien PC, Ballard DJ. Functioning insulinoma incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc. 1991;66:711–19. - PubMed
    1. Service FJ, Dale AJ, Elveback LR, Jiang NS. Insulinoma: clinical and diagnostic features of 60 consecutive cases. Mayo Clin Proc. 1976;51:417–29. - PubMed
    1. Stefanini P, Carboni M, Patrassi N, Basoli A. Beta-islet cell tumors of the pancreas: results of a study on 1,067 cases. Surgery. 1974;75:597–609. - PubMed
    1. Galbut DL, Markowitz AM. Insulinoma: diagnosis, surgical management and long-term follow-up. Review of 41 cases. Am J Surg. 1980;139:682–90. - PubMed
    1. Fajans SS, Vinik AI. Insulin-producing islet cell tumors. Endocrinol Metab Clin North Am. 1989;18:45–74. - PubMed